forgemax.FORGED. TESTED. PROVEN.
Deca-Phenylpropionate 100mg/ml 10x1ml Ampullen by Pharma Group
Athletes' Choice

Deca-Phenylpropionate 100mg/ml 10x1ml Ampullen by Pharma Group

Pharma Group Deca-Phenylpropionate delivers Nandrolone Phenylpropionate at 100 mg/ml in single-dose 1 ml glass ampoules, purpose-built for microdosing protocols that sustain low, continuous anabolic stimulus without the plasma swings associated with larger, infrequent injections. The 10×1 ml ampoule format makes precise sub-100 mg increments straightforward, supporting the kind of disciplined dose control that microdosing practitioners prioritise. Quality is anchored at the batch level: HPLC potency verification and LAL endotoxin clearance are conducted prior to release, with each ampoule sealed under pharmaceutical-grade conditions.

€54.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Enables precise 25 mg incremental dosing, ideal for structured microdosing frequency planning
  • Single-dose ampoule format preserves sterility across elevated weekly injection counts
  • 100 mg/ml concentration provides wider syringe-graduation margins for sub-50 mg accuracy
  • Nandrolone phenylpropionate's ester kinetics align well with every-other-day and daily microdose scheduling
  • Connective-tissue collagen synthesis support documented in hydroxyproline-output research at low weekly dose ranges
  • HPLC-confirmed potency ensures milligram fidelity critical when each injection is a small fraction of weekly total
  • LAL endotoxin clearance at batch level reduces inflammatory injection-site risk during high-frequency use

Key takeaways

  • Split your weekly NPP total across five or six small injections for stable plasma levels.
  • Draw exactly 25 mg per 0.25 ml using Pharma Group's 100 mg/ml concentration.
  • Open each single-dose ampoule once to maintain full sterility at high injection frequency.
  • Prioritise microdosing when nandrolone serves a joint-support role rather than primary anabolism.
  • Confirm HPLC batch documentation before starting any precision low-dose protocol.

Nandrolone Phenylpropionate as a Microdosing Agent

Deca-Phenylpropionate by Pharma Group is a single-ingredient injectable preparation of Nandrolone Phenylpropionate at 100 mg/ml, formulated in 10×1 ml glass ampoules specifically suited to microdosing protocols — an approach centred on delivering frequent, low-milligram doses that keep circulating nandrolone within a narrow, functional band rather than spiking it toward supraphysiological peaks. Microdosing, in this context, typically means administering 25–50 mg per injection across four to six weekly sessions rather than consolidating the same weekly total into one or two large doses. Pharma Group's 100 mg/ml concentration translates each 0.25 ml draw into exactly 25 mg, enabling the kind of granular control that high-concentration formats make arithmetically awkward.

How Microdosing Differs From Conventional NPP Protocols

Conventional Nandrolone Phenylpropionate cycles concentrate weekly totals — commonly 150–300 mg — into two larger injections, producing a pronounced peak-to-trough oscillation across the week. Microdosing redistributes that same weekly milligram total across daily or every-other-day administrations, flattening the plasma curve measurably compared to twice-weekly scheduling. Published pharmacokinetic modelling of esterified nandrolone suggests that dosing frequency, rather than total weekly dose alone, is the primary lever controlling plasma variability. Flatter plasma nandrolone correlates with more consistent androgen receptor occupancy — a mechanistic basis supported by receptor-binding data from in vitro myotube models — and may reduce the magnitude of LH and FSH suppression oscillations observed with pulsatile high-dose delivery.

Who Benefits Most From a Microdosing Structure

Microdosing protocols are best matched to athletes managing connective-tissue recovery during high-frequency training blocks, practitioners using nandrolone as a supportive adjunct rather than a primary anabolic driver, and individuals with documented sensitivity to androgenic side effects at higher dose ranges. A weekly total of 100–150 mg distributed across five to six injections sits comfortably within the therapeutic-adjacent range studied for joint and tendon collagen support, without the suppression load that accompanies legacy high-gram approaches. The 10×1 ml single-dose ampoule format reinforces this protocol structurally: each ampoule is opened, drawn, and used once, eliminating the cross-contamination risk inherent in multi-use vials — a sterility advantage that becomes especially relevant when injection frequency is elevated.

Dose Accountability and Quality Assurance

Pharma Group subjects each production batch to reversed-phase HPLC potency analysis and LAL (Limulus Amebocyte Lysate) endotoxin testing before distribution is authorised. Milligram accuracy is non-negotiable in microdosing contexts: a 10 % potency deviation at 25 mg per injection produces a proportionally larger relative error in effective receptor stimulus than the same deviation at 100 mg. The single-dose ampoule format provides a secondary quality layer — one-time-use glass ampoules eliminate the multi-puncture sterility degradation that can occur in rubber-septum vials reused across a multi-week microdosing run.

Usage

  1. Calculate your target weekly milligram total first, then divide by your chosen injection frequency (four, five, or six sessions) to determine the per-injection volume at 100 mg/ml.
  2. Select injection sites that can accommodate elevated rotation frequency — rotate among glutes, quads, and delts systematically to prevent localised tissue fatigue across the week.
  3. Remove one ampoule from refrigerated storage approximately 30 minutes before injection; allowing it to reach room temperature reduces solution viscosity and eases the draw.
  4. Open the scored glass ampoule with a clean snap, draw the precise calculated volume into a 1 ml syringe, then fit a fresh injection needle — never inject with the draw needle.
  5. Administer intramuscularly at a 90-degree angle into the prepared, swabbed site; aspirate briefly, then deliver slowly to minimise depot pressure and post-injection discomfort.
  6. Discard the opened ampoule and needle immediately after use — do not store partially used ampoules or reuse equipment, as the single-dose format provides its sterility advantage only when this discipline is maintained.

Warnings

Contraindications: Not indicated for individuals with known androgen-dependent neoplasms, active cardiovascular disease, liver pathology, or hypersensitivity to nandrolone or sesame/arachis-based carrier oils. Contraindicated during pregnancy and in pre-menopausal women without endocrinological oversight.

Side Effects: Nandrolone phenylpropionate carries progestogenic activity that may elevate prolactin in susceptible individuals; monitor for lactation-related symptoms in long or high-frequency cycles. Androgenic effects — acne, altered sebum production, potential hair-follicle sensitivity — are typically milder than with testosterone at equivalent doses. Endogenous testosterone suppression occurs at all dose levels and requires structured PCT.

Monitoring: Obtain a full hormonal panel (LH, FSH, total testosterone, prolactin, haematocrit, lipid profile) at baseline and at weeks 4 and 8 of any microdosing run. Prolactin elevation, if detected, may warrant dopamine-agonist intervention (cabergoline); decisions should be guided by a qualified healthcare professional. Haematocrit should remain below 52 % throughout.

PCT: Initiate selective oestrogen receptor modulator (SERM)-based PCT once plasma nandrolone has cleared sufficiently following the final injection — the phenylpropionate ester's relatively short depot release window allows PCT entry earlier than decanoate-ester formulations. Standard SERM protocols (clomiphene or tamoxifen) over four weeks are appropriate for most microdosing cycle lengths.

Frequently asked questions

What exactly is a microdosing protocol for Nandrolone Phenylpropionate?
A microdosing protocol for Nandrolone Phenylpropionate means dividing the intended weekly milligram total into small, frequent injections — typically 25–50 mg administered four to six times per week — rather than two larger doses. The goal is to maintain a consistently narrow plasma nandrolone band, reducing peak-to-trough swings and supporting steadier androgen receptor occupancy throughout the training week.
What are the practical benefits of running low, continuous NPP doses compared to standard twice-weekly injections?
Running low, continuous doses flattens the plasma nandrolone curve, which translates to more stable receptor activation and potentially less pronounced hormonal fluctuation between injections. Practitioners report more predictable connective-tissue support and a reduced acute suppression pulse compared to consolidating the same weekly total into two large shots. The tradeoff is injection frequency, which the single-dose ampoule format manages cleanly.
Who are Nandrolone Phenylpropionate microdosing protocols best suited for?
Microdosing NPP suits athletes using nandrolone primarily for tendon and joint support during high-frequency training, those sensitive to androgenic effects at conventional doses, and advanced practitioners who want granular control over their hormonal environment. It is also appropriate for individuals using nandrolone as a secondary adjunct compound rather than the primary anabolic agent in a stack.
Why does the 10x1ml single-dose ampoule format matter specifically for high-frequency microdosing?
Single-dose ampoules eliminate the repeated septum puncture required with multi-use vials. When injection frequency rises to five or six sessions per week, a rubber septum vial accumulates multiple punctures, increasing particulate contamination and sterility risk over time. Each 1 ml glass ampoule in this format is opened once, drawn once, and discarded — keeping every injection sterile regardless of protocol frequency.
How does the 100mg/ml concentration make microdose measurement more accurate than higher-concentration NPP products?
At 100 mg/ml, a 25 mg microdose corresponds to 0.25 ml — a clearly readable graduation on a standard 1 ml syringe. Higher-concentration formats at 150 mg/ml or above compress that same 25 mg dose into a smaller volume (approximately 0.17 ml), where minor syringe-reading errors represent a proportionally larger milligram deviation. The 100 mg/ml concentration therefore provides a wider, more forgiving measurement window for sub-50 mg doses. (2) angle_used

Manufacturer

Pharma Group's distribution and logistics infrastructure for the Deca-Phenylpropionate 100 mg/ml line is structured around a single operational priority: ensuring that every ampoule reaching an end user carries an unbroken chain of physical and documentary integrity from the point of batch release to the point of delivery. The ten-ampoule carton format used for this product reflects a deliberate packaging decision — individual ampoules are nested within moulded inserts that prevent ampoule-to-ampoule contact during transit, a mechanical protection measure that matters particularly for glass primary containers shipped across multi-leg international logistics chains where vibration and temperature excursion risk is cumulative. Cold-chain compliance documentation accompanies export consignments where destination-country storage regulations require temperature logging, with data-logger records available upon request through Pharma Group's distribution network rather than requiring direct manufacturer contact. The brand's regional distribution agreements are structured to maintain stock availability in key European and international markets without routing through grey-market intermediaries — a supply-chain discipline that reduces the probability of counterfeit product entering the distribution pipeline at any point between factory gate and registered supplier.

Product details

BrandPharma Group
Active ingredientnandrolone phenylpropionate
Also known asNPP, Durabolin, Nandrolone Phenylpropionate, Deca-Phenylpropionatee, Pharma Group NPP
Strength100 mg
FormAmpullen
Pack size10 pieces
Item numberINJ-NAPP-PHG-100-013

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Pheno-NPP 100mg/ml 10ml Vial by Beligas PharmaceuticalsFast Acting

Pheno-NPP 100mg/ml 10ml Vial by Beligas Pharmaceuticals

€48.00
NPP 150 100mg/ml 10ml Vial by Dragon-PharmaOptimal Dosage

NPP 150 100mg/ml 10ml Vial by Dragon-Pharma

€45.00
Nanphenylos 100mg/ml 10ml Vial by Driada MedicalHigh Concentration

Nanphenylos 100mg/ml 10ml Vial by Driada Medical

€40.00
Nandrolone Phenylpropionate 100mg/ml 10x1ml Ampoules by Elbrus PharmaceuticalsBrand Quality

Nandrolone Phenylpropionate 100mg/ml 10x1ml Ampullen by Elbrus Pharmaceuticals

€56.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00